Professor Bill Denny
Professor Bill Denny is the Director of the Auckland Cancer Society Research Centre (ACSRC), and was made a Distinguished Professor at the University of Auckland in 2011. He currently is a leader in the Maurice Wilkins Centre ‘Immuno-oncology’ flagship. His interests include the design and evaluation of small-molecule drugs and he has been involved in the development of 14 drugs to clinical trial. He has been a founding scientist of three biotechnology companies (Proacta Inc, Pathway Therapeutics Ltd and Kea Therapeutics).
He received his PhD (organic synthesis) and DSc (drug design) degrees from the University of Auckland, then accepted a post-doctoral position at Oxford University. Included in Prof Denny’s many achievements are induction into the American Chemical Society’s Medicinal Chemistry Hall of Fame in 2016. Among his awards are Officer of the New Zealand Order of Merit (ONZM), the Rutherford Medal of the Royal Society of New Zealand (1995), the Adrien Albert Medal of the UK Royal Society of Chemistry (2005) and the 2014 Medicinal Chemistry award of the American Chemical Society.